Biotechnology at ATI
Biotechnology is central to national security, public health, and preparedness. ATI builds and manages collaborative R&D environments that enable rapid development, testing, and deployment of critical bio-innovations.
ATI’s role in biotechnology:
- Builds and manages purpose-driven consortia aligned to federal biosecurity priorities
- Connects nontraditional innovators to government-led research initiatives
- Accelerates medical countermeasure and vaccine development timelines
- Reduces operational and contracting complexity for program teams
Biotechnology Consortia
ATI manages biotechnology-focused consortia that bring together government, industry, and academia to accelerate outcomes.
Key Focus Areas
Medical Countermeasures
Development of vaccines, therapeutics, and diagnostics to address biological threats and emerging diseases.
Biopharmaceutical Manufacturing
Scaling resilient, domestic manufacturing capabilities for drugs, vaccines, and critical materials.
Pandemic Preparedness & Response
Rapid-response innovation networks to address future public health emergencies.
Biosecurity & Threat Detection
Technologies that identify, monitor, and mitigate biological risks in real time.
Human Performance & Protection
Solutions that enhance health, readiness, and recovery for military and civilian populations.
Advanced Diagnostics
Next-generation tools for faster, more accurate disease detection and clinical decision-making.
Explore live and upcoming research and development opportunities across ATI-managed biotech and health security related consortia. From weapons of mass destruction and biosecurity to advanced manufacturing and medical technologies, these opportunities support mission-critical innovation across the federal space.
Biotechnology Collaboration Events
ATI exists to lessen the burden on government by building and leading R&D and prototyping collaborations that solve urgent national challenges at mission speed.
We bring together nontraditional innovators, federal agencies, and research institutions in purpose-built consortia that accelerate outcomes, reduce risk, and strengthen national security.
Explore current and upcoming collaboration events, training, and conferences, we will be participating in or hosting within our Biotechnology domain.
